Related references
Note: Only part of the references are listed.Nanoconjugate based on polymalic acid for tumor targeting
Julia Y. Ljubimova et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2008)
Brain tumor tandem targeting using a combination of monoclonal antibodies attached to biopoly(β-L-malic acid)
Manabu Fujita et al.
JOURNAL OF CONTROLLED RELEASE (2007)
Pegaptanib and ranibizumab for neovascular age-related macular degeneration: a systematic review
A. L. Takeda et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2007)
Monoclonal antibody 2C5-modified doxorubicin-loaded liposomes with significantly enhanced therapeutic activity against intracranial human brain U-87 MG tumor xenografts in nude mice
Bhawna Gupta et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
A synthetic small molecule, ONO-1301, enhances endogenous growth factor expression and augments angiogenesis in the ischaemic heart
Kazuto Nakamura et al.
CLINICAL SCIENCE (2007)
Therapeutic targets in chronic myeloid leukaemia
Nicholas B. Heaney et al.
HEMATOLOGICAL ONCOLOGY (2007)
Glaucoma as a neurodegenerative disease
Neeru Gupta et al.
CURRENT OPINION IN OPHTHALMOLOGY (2007)
Molecular targeted therapy for carcinoid and islet-cell carcinoma
James C. Yao
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Lapatinib: a dual inhibitor of EGFR and HER2 tyrosine kinase activity
Filippo Montemurro et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2007)
Protein kinase CK2: a newcomer in the 'druggable kinome'
M. A. Pagano et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2006)
Concomitant inhibition of epidermal growth factor and vascular endothelial growth factor receptor tyrosine kinases reduces growth and metastasis of human salivary adenoid cystic carcinoma in an orthotopic nude mouse model
Maher N. Younes et al.
MOLECULAR CANCER THERAPEUTICS (2006)
FK228 (depsipeptide): a HDAC inhibitor with pleiotropic antitumor activities
Panagiotis A. Konstantinopoulos et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2006)
The transferrin receptor part I: Biology and targeting with cytotoxic antibodies for the treatment of cancer
Tracy R. Daniels et al.
CLINICAL IMMUNOLOGY (2006)
The transferrin receptor part II: Targeted delivery of therapeutic agents into cancer cells
Tracy R. Daniels et al.
CLINICAL IMMUNOLOGY (2006)
CK2 signaling in androgen-dependent and -independent prostate cancer
Guixia Wang et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2006)
Properties of HPMA copolymer-doxorubicin conjugates with pH-controlled activation:: Effect of polymer chain modification
Petr Chytil et al.
JOURNAL OF CONTROLLED RELEASE (2006)
Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras
James O. McNamara et al.
NATURE BIOTECHNOLOGY (2006)
Glutamate-induced apoptosis in neuronal cells is mediated via caspase-dependent and independent mechanisms involving calpain and caspase-3 proteases as well as apoptosis inducing factor (AIF) and this process is inhibited by equine estrogens
YueMei Zhang et al.
BMC NEUROSCIENCE (2006)
Improving the delivery of therapeutic agents to CNS neoplasms: a clinical review
MA Badruddoja et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2006)
Expression of protein kinase CK2 in astroglial cells of normal and neovascularized retina
AA Kramerov et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
Polycefin, a new prototype of a multifunctional nonconjugate based on poly(β-L-malic acid) for drug delivery
BS Lee et al.
BIOCONJUGATE CHEMISTRY (2006)
Antibody targeted drugs as cancer therapeutics
D Schrama et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
The penetration of anticancer drugs through tumor tissue as a function of cellular adhesion and packing density of tumor cells
R Grantab et al.
CANCER RESEARCH (2006)
Safety, pharmacokinetic, and antitumor activity of SU11248, a novel oral multitarget tyrosine kinase inhibitor, in patients with cancer
S Faivre et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Polymer conjugates as anticancer nanomedicines
Ruth Duncan
NATURE REVIEWS CANCER (2006)
Multifunctional polymeric micelles with folate-mediated cancer cell targeting and pH-triggered drug releasing properties for active intracellular drug delivery
Y Bae et al.
MOLECULAR BIOSYSTEMS (2005)
Expression and function of laminins in the embryonic and mature vasculature
R Hallmann et al.
PHYSIOLOGICAL REVIEWS (2005)
Polymer-drug conjugates: towards a novel approach for the treatment of endrocine-related cancer
R Duncan et al.
ENDOCRINE-RELATED CANCER (2005)
Delivery of β-galactosidase to mouse brain via the blood-brain barrier transferrin receptor
Y Zhang et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Cationic albumin conjugated pegylated nanoparticle with its transcytosis ability and little toxicity against blood-brain barrier
W Lu et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2005)
Role of nonfeminizing estrogen analogues in neuroprotection of rat retinal ganglion cells against glutamate-induced cytotoxicity
DM Kumar et al.
FREE RADICAL BIOLOGY AND MEDICINE (2005)
Targeting therapeutic and imaging agents to folate receptor positive tumors
JA Reddy et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2005)
Nanomedicine: current status and future prospects
SM Moghimi et al.
FASEB JOURNAL (2005)
Intracellular targeting of polymer-bound drugs for cancer chemotherapy
A Nori et al.
ADVANCED DRUG DELIVERY REVIEWS (2005)
Overexpression of beta 1-chain-containing laminins in capillary basement membranes of human breast cancer and its metastases
M Fujita et al.
BREAST CANCER RESEARCH (2005)
Folate-targeted chemotherapy
CP Leamon et al.
ADVANCED DRUG DELIVERY REVIEWS (2004)
Genetically engineered polymers: status and prospects for controlled release
M Haider et al.
JOURNAL OF CONTROLLED RELEASE (2004)
Bioadhesive grafted starch copolymers as platforms for peroral drug delivery: a study of theophylline release
S Geresh et al.
JOURNAL OF CONTROLLED RELEASE (2004)
Association between laminin-8 and glial tumor grade, recurrence, and patient survival
JY Ljubimova et al.
CANCER (2004)
Involvement of protein kinase CK2 in angiogenesis and retinal neovascularization
AV Ljubimov et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2004)
Rac regulates integrin-mediated endothelial cell adhesion and migration on laminin-8
H Fujiwara et al.
EXPERIMENTAL CELL RESEARCH (2004)
Intravenous RNA interference gene therapy targeting the human epidermal growth factor receptor prolongs survival in intracranial brain cancer
Y Zhang et al.
CLINICAL CANCER RESEARCH (2004)
In vitro cytotoxicity and in vivo distribution after direct delivery of PEG-camptothecin conjugates to the rat brain
AB Fleming et al.
BIOCONJUGATE CHEMISTRY (2004)
Mucoadhesive thiolated chitosans as platforms for oral controlled drug delivery: synthesis and in vitro evaluation
M Roldo et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2004)
Poly(γ-D-glutamic acid) protein conjugates induce IgG antibodies in mice to the capsule of Bacillus anthracis:: A potential addition to the anthrax vaccine
R Schneerson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Pollycation gene delivery systems: escape from endosomes to cytosol
YW Cho et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2003)
Peptide and protein drug delivery to and into tumors: challenges and solutions
VP Torchilin et al.
DRUG DISCOVERY TODAY (2003)
PEGylated nanoparticles for biological and pharmaceutical applications
H Otsuka et al.
ADVANCED DRUG DELIVERY REVIEWS (2003)
Effective drug delivery by PEGylated drug conjugates
RB Greenwald et al.
ADVANCED DRUG DELIVERY REVIEWS (2003)
Drug delivery strategy utilizing conjugation via reversible disulfide linkages: role and site of cellular reducing activities
G Saito et al.
ADVANCED DRUG DELIVERY REVIEWS (2003)
Pharmacokinetics of pegylated liposomal doxorubicin - Review of animal and human studies
A Gabizon et al.
CLINICAL PHARMACOKINETICS (2003)
Endosomolysis by masking of a membrane-active agent (EMMA) for cytoplasmic release of macromolecules
DB Rozema et al.
BIOCONJUGATE CHEMISTRY (2003)
Polyacetal-doxorubicin conjugates designed for pH-dependent degradation
R Tomlinson et al.
BIOCONJUGATE CHEMISTRY (2003)
Therapeutic antibodies for human diseases at the dawn of the twenty-first century
OH Brekke et al.
NATURE REVIEWS DRUG DISCOVERY (2003)
Targeted drug delivery via the transferrin receptor-mediated endocytosis pathway
ZM Qian et al.
PHARMACOLOGICAL REVIEWS (2002)
Drug and gene delivery to the brain: The vascular route
WM Pardridge
NEURON (2002)
Pluronic® block copolymers for overcoming drug resistance in cancer
AV Kabanov et al.
ADVANCED DRUG DELIVERY REVIEWS (2002)
Poly(L-glutamic acid) - anticancer drug conjugates
C Li
ADVANCED DRUG DELIVERY REVIEWS (2002)
Prospects for cationic polymers in gene and oligonucleotide therapy against cancer
T Merdan et al.
ADVANCED DRUG DELIVERY REVIEWS (2002)
Antisense oligonucleotides delivered to the lysosome escape and actively inhibit the hepatitis B virus
KD Jensen et al.
BIOCONJUGATE CHEMISTRY (2002)
Functional characterization of an endosome-disruptive peptide and its application in cytosolic delivery of immunoliposome-entrapped proteins
E Mastrobattista et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Characterization of a novel pH-sensitive peptide that enhances drug release from folate-targeted liposomes at endosomal pHs
MJ Turk et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2002)
The impact of efflux transporters in the brain on the development of drugs for CNS disorders
EM Taylor
CLINICAL PHARMACOKINETICS (2002)
Polysaccharides in colon-specific drug delivery
VR Sinha et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2001)
Water soluble polymers in tumor targeted delivery
J Kopecek et al.
JOURNAL OF CONTROLLED RELEASE (2001)
New HPMA copolymers containing doxorubicin bound via pH-sensitive linkage:: synthesis and preliminary in vitro and in vivo biological properties
T Etrych et al.
JOURNAL OF CONTROLLED RELEASE (2001)
Characteristics of tissue distribution of various polysaccharides as drug carriers: Influences of molecular weight and anionic charge on tumor targeting
S Sugahara et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2001)
Cyclosporin A targets involved in protection against glutamate excitotoxicity
F Ruiz et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2000)
Biodistribution of fluoresceinated dextran using novel nanoparticles evading reticuloendothelial system
U Gaur et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2000)
HPMA copolymer-anticancer drug conjugates:: design, activity, and mechanism of action
J Kopecek et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2000)
Transport across the primate blood-brain barrier of a genetically engineered chimeric monoclonal antibody to the human insulin receptor
MJ Coloma et al.
PHARMACEUTICAL RESEARCH (2000)
Stability of the disulfide bond in an avidin-biotin linked chimeric peptide during in vivo transcytosis through brain endothelial cells
YS Kang et al.
JOURNAL OF DRUG TARGETING (2000)
HPMA copolymer-anticancer drug-OV-TL16 antibody conjugates. 3. The effect of free and polymer-bound Adriamycin on the expression of some genes in the OVCAR-3 human ovarian carcinoma cell line
K Kunath et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2000)
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
H Maeda et al.
JOURNAL OF CONTROLLED RELEASE (2000)
Share Paper
